Evidence map›Paper›PMID 30841888›Full record

ArticleBMC public health2019

A cross-country study of mis-implementation in public health practice.

Karishma S Furtado, Elizabeth L Budd, Rebecca Armstrong, Tahna Pettman, Rodrigo Reis, Pauline Sung-Chan, Zhaoxin Wang, Ross C Brownson

Abstract read
In one paragraph

Article in BMC public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Characterisation of At-Scale Community Health Interventions Aimed to Improve Healthy Eating Behaviour in Australia: A Rapid Review.Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Karishma S FurtadoPrevention Research Center, Brown School, Washington University in St. Louis, One Brookings Dr., Campus Box 1196, St. Louis, MO, 63130, USA. kfurtado@wustl.edu.ORCID http://orcid.org/0000-0002-9430-9214
Elizabeth L BuddCollege of Education, University of Oregon, Eugene, OR, 97403, USA.
Rebecca ArmstrongMelbourne School of Population and Global Health, The University of Melbourne, Victoria, 3010, Australia.
Tahna PettmanMelbourne School of Population and Global Health, The University of Melbourne, Victoria, 3010, Australia.
Rodrigo ReisPrevention Research Center, Brown School, Washington University in St. Louis, One Brookings Dr., Campus Box 1196, St. Louis, MO, 63130, USA.
Pauline Sung-ChanHong Kong University of Science & Technology, Clear Water Bay, Kowloon, Hong Kong.
Zhaoxin WangTongji University, Shanghai, China.
Ross C BrownsonPrevention Research Center, Brown School, Washington University in St. Louis, One Brookings Dr., Campus Box 1196, St. Louis, MO, 63130, USA.

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Institute of Clinical and Translational Sciences (KL2) KL2TR002346 · NCATS · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 2017 to 2026
$14.0M
Washington University Center for Diabetes Translation Research P30DK092950 · NIDDK · WASHINGTON UNIVERSITY · PI Ross C Brownson, Debra Haire-Joshu · 2011 to 2026
$11.7M
Washington University Institute of Clinical and Translational SciencesKL2TR000450 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$8.8M
Washington University Institute of Clinical and Translational Sciences (TL1)TL1TR002344 · NCATS · WASHINGTON UNIVERSITY · PI Jay F. Piccirillo · 2017 to 2026
$8.5M
Disseminating Evidence-Based Interventions to Control CancerR01CA160327 · NCI · WASHINGTON UNIVERSITY · PI BROWNSON, ROSS C · 2012 to 2017
$2.8M
A CROSS-COUNTRY COMPARISON OF EVIDENCE-BASED PREVENTION OF CANCERR21CA179932 · NCI · WASHINGTON UNIVERSITY · PI BROWNSON, ROSS C · 2014 to 2015
$366k
NCATS NIH HHS KL2 TR000450NCATS NIH HHS KL2 TR002346NCATS NIH HHS TL1 TR002344NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NCI NIH HHS 1R21CA179932-01A1NCI NIH HHS 5R01CA160327NCI NIH HHS R01 CA160327NCI NIH HHS R21 CA179932NIDDK NIH HHS 1P30DK092950NIDDK NIH HHS P30 DK092950
6 · The paper itself

Abstract

backgroundMis-implementation (i.e., the premature termination or inappropriate continuation of public health programs) contributes to the misallocation of limited public health resources and the sub-optimal response to the growing global burden of chronic disease. This study seeks to describe the occurrence of mis-implementation in four countries of differing sizes, wealth, and experience with evidence-based chronic disease prevention (EBCDP).

methodsA cross-sectional study of 400 local public health practitioners in Australia, Brazil, China, and the United States was conducted from November 2015 to April 2016. Online survey questions focused on how often mis-termination and mis-continuation occur and the most common reasons programs end and continue.

resultsWe found significant differences in knowledge of EBCDP across countries with upwards of 75% of participants from Australia (n = 91/121) and the United States (n = 83/101) reporting being moderately to extremely knowledgeable compared with roughly 60% (n = 47/76) from Brazil and 20% (n = 21/102) from China (p < 0.05). Far greater proportions of participants from China thought effective programs were never mis-terminated (12.2% (n = 12/102) vs. 1% (n = 2/121) in Australia, 2.6% (n = 2/76) in Brazil, and 1.0% (n = 1/101) in the United States; p < 0.05) or were unable to estimate how frequently this happened (45.9% (n = 47/102) vs. 7.1% (n = 7/101) in the United States, 10.5% (n = 8/76) in Brazil, and 1.7% (n = 2/121) in Australia; p < 0.05). The plurality of participants from Australia (58.0%, n = 70/121) and the United States (36.8%, n = 37/101) reported that programs often mis-continued whereas most participants from Brazil (60.5%, n = 46/76) and one third (n = 37/102) of participants from China believed this happened only sometimes (p < 0.05). The availability of funding and support from political authorities, agency leadership, and the general public were common reasons programs continued and ended across all countries. A program's effectiveness or evidence-base-or lack thereof-were rarely reasons for program continuation and termination.

conclusionsDecisions about continuing or ending a program were often seen as a function of program popularity and funding availability as opposed to effectiveness. Policies and practices pertaining to programmatic decision-making should be improved in light of these findings. Future studies are needed to understand and minimize the individual, organizational, and political-level drivers of mis-implementation.

Indexed as

AustraliaBrazilChinaChronic DiseaseCross-Sectional StudiesDecision MakingEvidence-Based PracticeHumansProgram EvaluationPublic Health AdministrationPublic Health PracticeUnited StatesChronic diseaseDissemination and implementationEvidence-based chronic disease preventionEvidence-based public healthMis-implementation

Identifiers

PMID30841888
PMCPMC6404329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.